13D Filing: Broadfin Capital and Novelion Therapeutics Inc. (NVLN)

Page 2 of 9 – SEC Filing

CUSIP No. 67001K202
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Broadfin Capital, LLC
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)   [_]
(b)   [x]
3. SEC USE ONLY
4. SOURCE OF FUNDS
AF, WC
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7. SOLE VOTING POWER
0
8. SHARED VOTING POWER
1,948,554*
9. SOLE DISPOSITIVE POWER
0
10. SHARES DISPOSITIVE POWER
1,948,554*
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
1,948,554*
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES [_]
CERTAIN SHARES*
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.42%
14. TYPE OF REPORTING PERSON
OO
 

* Please see Item 4 for description of certain restrictions pertaining
to the Reporting Persons’ exercise of the Warrants.

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)